The Anti-VEGF Landscape: Recent Advances & New Prospects
Time: 9:30 am
day: Day One
Details:
- Exploring how recently approved anti-VEGF drugs (Brolucizumab, Vabysmo, Susvimo) have focused on extending durability
- Overviewing how several extended-release strategies are being developed
- Elucidating combination therapy – Hopes of improving peak efficacy continues to be investigated but extending durability appears more achievable
